Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Wockhardt in Talks With Abbott to Sell Nutrition Unit
Bloomberg
Tuesday, November 23, 2010 - 10:35am
tags:
M&A, Wockhardt, Abbott Laboratories, nutrition
Still Hope for Novartis's $125 Million Acquisition of Zhejiang Tianyuan?
Seeking Alpha
Tuesday, November 23, 2010 - 10:23am
tags:
Novartis, M&A, Zhejiang Tianyuan Bio-Pharmaceutical
Teva Gets Boost From Biosimilars
Seeking Alpha
Tuesday, November 23, 2010 - 9:37am
tags:
Teva Pharmaceuticals, biosimilars, Lonza, small molecule drugs
Why Bayer Needs Luck as Much as It Needs Layoffs
BNET Pharma
Tuesday, November 23, 2010 - 9:32am
tags:
Bayer, layoffs, JNJ
Options Action: Johnson & Johnson
CNBC
Tuesday, November 23, 2010 - 9:28am
tags:
JNJ, options
Ariad Gets Good News on Its Endometrial Cancer Drug
Seeking Alpha
Tuesday, November 23, 2010 - 9:27am
tags:
endometrial cancer, Ariad Pharmaceuticals, Merck, mTOR inhibitors, ridaforolimus
J&J Recalls Children's Benadryl, Motrin Over Manufacturing `Deficiencies'
Bloomberg
Tuesday, November 23, 2010 - 9:25am
tags:
recalls, JNJ
Let's Call It a Partial Victory (Merck)
Motley Fool
Tuesday, November 23, 2010 - 8:57am
tags:
Merck, Vytorin, kidney disease
Abbott drug meets goals in kidney disease study
Yahoo/AP
Tuesday, November 23, 2010 - 8:56am
tags:
kidney cancer, Abbott Laboratories, atrasentan
Pfizer's Mixed Bag
Motley Fool
Tuesday, November 23, 2010 - 8:55am
tags:
Pfizer, Apixaban, JNJ, Boehringer Ingelheim, Bristol-Myers Squibb, Axitinib
Celldex advances brain tumor vaccine
Bizjournals.com
Tuesday, November 23, 2010 - 8:53am
tags:
vaccines, Celldex, brain tumors, brain cancer
Genzyme ($GENZ) proffers milestone-based deal to potential suitors
Fierce Biotech
Monday, November 22, 2010 - 12:43pm
tags:
Genzyme, milestone payments, Sanofi, M&A, Pfizer, Merck, JNJ
Merck, Vytorin & Questionable Oxford Researchers
Pharmalot
Monday, November 22, 2010 - 12:39pm
tags:
Merck, Vytorin
Apricus, FDA agree on design for late-stage study of liver cancer drug PrevOnco; stock surges
Yahoo/AP
Monday, November 22, 2010 - 12:35pm
tags:
Apricus Biosciences, FDA, liver cancer, PrevOnco
Biotech's Biggest R&D Spenders 2010
Fierce Biotech
Monday, November 22, 2010 - 10:45am
tags:
biotech, R&D, Amgen, Biogen Idec, Gilead Sciences, Genzyme, Celgene, Kyowa Hakko Kirin, Vertex Pharmaceuticals, Life Technologies, CSL, Amylin, Genmab, Cubist Pharmaceuticals, MannKind, companies, Merial
Cornerstone ending sale of certain painkillers
Yahoo/AP
Monday, November 22, 2010 - 10:42am
tags:
Cornerstone Therapeutics, painkillers, propoxyphene, FDA, Darvon
Merck Wins Third Fosamax Trial; Record Now Stands at 2-1
WSJ Online
Monday, November 22, 2010 - 10:41am
tags:
Merck, Fosamax, lawsuits
Regeneron Rises After Eye Drug Matches Lucentis With Fewer Doses
Bloomberg
Monday, November 22, 2010 - 10:39am
tags:
Lucentis, Regeneron, Bayer, macular degeneration, Roche, age-related macular degeneration, VEGF Trap-Eye
Shionogi Needs Sales Reps, But No Reps Need Apply
Pharmalot
Monday, November 22, 2010 - 10:37am
tags:
Shionogi, drug reps
Painful Pharmaceutical Industry Downsizing was Avoidable
Pharmareform
Monday, November 22, 2010 - 10:37am
tags:
layoffs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.